RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 104 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $625,000 | +110.4% | 143,966 | +3.6% | 0.01% | -7.7% |
| Q4 2019 | $297,000 | -34.9% | 139,010 | -43.0% | 0.01% | -18.8% |
| Q3 2019 | $456,000 | -0.9% | 244,091 | +38.6% | 0.02% | +23.1% |
| Q2 2019 | $460,000 | +110.0% | 176,158 | +106.3% | 0.01% | +44.4% |
| Q1 2019 | $219,000 | +0.9% | 85,382 | +53.0% | 0.01% | +50.0% |
| Q4 2017 | $217,000 | +40.0% | 55,806 | +32.1% | 0.01% | +50.0% |
| Q3 2016 | $155,000 | +138.5% | 42,241 | +44.4% | 0.00% | +300.0% |
| Q2 2016 | $65,000 | +6.6% | 29,251 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $61,000 | -4.7% | 29,251 | +38.5% | 0.00% | 0.0% |
| Q4 2015 | $64,000 | +36.2% | 21,113 | +11.6% | 0.00% | 0.0% |
| Q3 2015 | $47,000 | -21.7% | 18,913 | +1.1% | 0.00% | 0.0% |
| Q2 2015 | $60,000 | +22.4% | 18,713 | +35.5% | 0.00% | 0.0% |
| Q1 2015 | $49,000 | +14.0% | 13,814 | +15.6% | 0.00% | 0.0% |
| Q2 2014 | $43,000 | -4.4% | 11,950 | +2.3% | 0.00% | 0.0% |
| Q1 2014 | $45,000 | – | 11,687 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
| HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
| GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
| CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
| SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
| Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
| Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
| DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
| Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |